首页> 外文期刊>Neuropharmacology >Identification and validation of midbrain Kcnq4 regulation of heavy alcohol consumption in rodents
【24h】

Identification and validation of midbrain Kcnq4 regulation of heavy alcohol consumption in rodents

机译:中脑KCNQ4中靶标鉴定及验证啮齿动物重度醇消费调控

获取原文
获取原文并翻译 | 示例
           

摘要

Currently available pharmacotherapies for treating alcohol use disorder (AUD) suffer from deleterious side effects and are not efficacious in diverse populations. Clinical and preclinical studies provide evidence that the Kcnq family of genes that encode K(v)7 channels influence alcohol intake and dependence. K(v)7 channels are a class of slowly activating voltage-dependent K+ channels that regulate neuronal excitability. Studies indicate that the K(v)7 channel positive modulator retigabine can decrease dopaminergic neuron firing, alter dopamine (DA) release, and reduce alcohol intake in heavy drinking rodents. Given the critical nature of ventral tegmental area (VTA) DA to the addiction process and predominant expression of Kcnq4 in DA neurons, we investigated the role of midbrain Kcnq genes and K(v)7 channels in the VTA of genetically diverse mice and long-term heavy drinking rats, respectively. Integrative bioinformatics analysis identified negative correlations between midbrain Kcnq4 expression and alcohol intake and seeking behaviors. Kcnq4 expression levels were also correlated with dopaminergic-related phenotypes in BXD strains, and Kcnq4 was present in support intervals for alcohol sensitivity and alcohol withdrawal severity QTLs in rodents. Pharmacological validation studies revealed that VTA K(v)7 channels regulate excessive alcohol intake in rats with a high-drinking phenotype. Administration of a novel and selective K(v)7.2/4 channel positive modulator also reduced alcohol drinking in rats. Together, these findings indicate that midbrain Kcnq4 expression regulates alcohol-related behaviors in genetically diverse mice and provide evidence that K(v)7.4 channels are a critical mediator of excessive alcohol drinking. (C) 2018 Elsevier Ltd. All rights reserved.
机译:目前可用的药房治疗酒精使用障碍(AUD)患有有害的副作用,并且在不同的人群中并不有效。临床和临床前研究提供了编码K(v)7通道的KCNQ基因的基因影响酒精摄入和依赖性。 K(v)7通道是一类缓慢激活的电压依赖性K +通道,其调节神经元兴奋性。研究表明,K(v)7沟道阳性调节剂重载扣式萘胺可降低多巴胺能神经元烧制,改变多巴胺(DA)释放,并减少重饮用啮齿动物的酒精摄入量。鉴于腹侧区域(VTA)DA对达神经元的成瘾过程(VTA)DA的临界性质和KCNQ4的主要表达,我们研究了中脑KCNQ基因和K(v)7频道在遗传多样性小鼠的VTA中的作用和长期分别是重饮料大鼠。一体化生物信息学分析确定了中脑KCNQ4表达与酒精摄入量和寻求行为之间的负相关性。 KCNQ4表达水平也与BXD菌株中的多巴胺能相关表型相关,并且KCNQ4以甲醇敏感性和饮料中的乙醇敏感性的载体敏感性QTL存在。药理学验证研究表明,VTA K(v)7通道调节大鼠的过量醇摄入量,具有高饮用表型。新型和选择性K(v)7.2 / 4通道阳性调节剂的施用也减少了大鼠的酒精饮用。这些发现表明,中脑KCNQ4表达调节遗传多样性小鼠中的酒精相关行为,并提供了K(v)7.4频道是过量酒精饮用的临界介质。 (c)2018年elestvier有限公司保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号